Optellum News | Lung Cancer AI Company Updates | Optellum (5)

02 March 2021 / Department for International Trade

Optellum named by the UK government as one of the top 100 digital health companies

15 January 2021 / 2020

Clinical study demonstrates benefit of Optellum AI-assisted diagnosis for lung cancer

Dr Vachani presented a virtual poster as a three-minute video as part of a session that highlighted lung cancer projects across the continuum of care.

07 July 2020 / Partnerships

Optellum partners with University of Oxford in £11 million AI programme to accelerate lung cancer diagnosis

30 April 2020 / Clinical & Regulatory

Optellum’s lung cancer prediction AI is clinically validated in the top-ranked US respiratory journal

05 March 2020 / Clinical & Regulatory

Optellum’s lung cancer prediction AI is clinically validated in Thorax

13 February 2020 / Team & Culture

New Appointments Strengthen Leadership Team

17 October 2019 / Public Appearances

Optellum co-founder helps start the world's first AI university

18 September 2019 / Events

Optellum at AI@Oxford Conference

07 September 2019 / Events

Optellum Science at the World Conference on Lung Cancer

28 November 2018 / Insights

Optellum selected for TMCx Accelerator at the world's largest medical complex

06 November 2018 / Partnerships

Oxford secures £17.5 million to lead the world in imaging AI, in partnership with Optellum

27 September 2018 / Events

Optellum Science at the IASLC World Conference on Lung Cancer

22 June 2018 / Partnerships

Prof Sam Janes joins Optellum Medical Advisory Board

21 May 2018 / Events

Meet Optellum at the ATS 2018 Congress

18 March 2018 / US

US National Lung Screening Trial PI visits Optellum

13 February 2018 / Partnerships

Leo Grady joins Optellum's Scientific Advisory Board

05 January 2018 / Insights

BBC World News: Optellum could save the National Health Service

09 December 2017 / Partnerships

Prof Matthijs Oudkerk joins Optellum Medical Advisory Board

16 October 2017 / Partnerships

Optellum & EIT Health-funded consortium showcase their Virtual Lung Clinic at IASLC 18th WCLC in Yokohama Japan

11 September 2017 / Events

Optellum CSTO presents 'Machine Learning for Medical Imaging' webinar at the British Institute of Radiology

12 November 2016 / Partnerships

‘Dr Computer’ aids intelligent lung cancer diagnoses

Optellum and RapidAI Bring AI-Supported Lung Nodule Management to the Rapid Enterprise™ Platform

Optellum named by the UK government as one of the top 100 digital health companies

Optellum’s year in review

Optellum expands its commercial team in readiness for US sales

Optellum set to take off in 2021 according to Business Insider

Clinical study demonstrates benefit of Optellum AI-assisted diagnosis for lung cancer

Optellum partners with University of Oxford in £11 million AI programme to accelerate lung cancer diagnosis

Optellum’s lung cancer prediction AI is clinically validated in the top-ranked US respiratory journal

Optellum’s lung cancer prediction AI is clinically validated in Thorax

New Appointments Strengthen Leadership Team

Optellum co-founder helps start the world's first AI university

Optellum at AI@Oxford Conference

Optellum Science at the World Conference on Lung Cancer

Optellum selected for TMCx Accelerator at the world's largest medical complex

Oxford secures £17.5 million to lead the world in imaging AI, in partnership with Optellum

Optellum Science at the IASLC World Conference on Lung Cancer

Prof Sam Janes joins Optellum Medical Advisory Board

Meet Optellum at the ATS 2018 Congress

US National Lung Screening Trial PI visits Optellum

Leo Grady joins Optellum's Scientific Advisory Board

BBC World News: Optellum could save the National Health Service

Prof Matthijs Oudkerk joins Optellum Medical Advisory Board

Optellum & EIT Health-funded consortium showcase their Virtual Lung Clinic at IASLC 18th WCLC in Yokohama Japan

Optellum CSTO presents 'Machine Learning for Medical Imaging' webinar at the British Institute of Radiology

‘Dr Computer’ aids intelligent lung cancer diagnoses

Redefining early intervention of lung disease starting with one of the deadliest, lung cancer